Overview

GnRH Agonist as Luteal Support in FET Cycles

Status:
Completed

Trial end date:
2015-10-01

Target enrollment:

Participant gender:

Summary

Back ground: A single dose of GnRH analogue in the luteal phase is reported to improve the outcome of IVF/ICSI treatments but the effect in FET cycles has not been reported. Aim: To compare the results of frozen thawed embryo transfers with and without GnRHa analogue support Primary end point: IR, PR, on going PR Secondary end point: hCH, E2 and progesterone levels 14 days after thawing

Phase:

Phase 4

Details

Lead Sponsor:

Turku University Hospital

Treatments:

Hormones
Triptorelin Pamoate